Related references
Note: Only part of the references are listed.Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Qing Chen et al.
DIABETES THERAPY (2019)
Effect of Antidiabetic Treatment on Bone
P. Jackuliak et al.
PHYSIOLOGICAL RESEARCH (2019)
Diabetes pharmacotherapy and effects on the musculoskeletal system
Evangelia Kalaitzoglou et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
Oriana Yu et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Thiazolidinediones as antidiabetic agents: A critical review
M. J. Nanjan et al.
BIOORGANIC CHEMISTRY (2018)
Type 2 diabetes mellitus and bone
J. Compston
JOURNAL OF INTERNAL MEDICINE (2018)
The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus
C. Sarodnik et al.
MATURITAS (2018)
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
Peter Ueda et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Mechanisms of diabetes mellitus-induced bone fragility
Nicola Napoli et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
PREVALENCE AND RISK FACTORS OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES MELLITUS
Ivan Raska et al.
CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2017)
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
Antonios Douros et al.
DIABETES CARE (2017)
Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study
Johanna H. M. Driessen et al.
DIABETES OBESITY & METABOLISM (2017)
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Merlin C. Thomas et al.
NATURE REVIEWS NEPHROLOGY (2016)
Review of Hypoglycemia in the Older Adult: Clinical Implications and Management
Mousumi Sircar et al.
CANADIAN JOURNAL OF DIABETES (2016)
Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus
Kate L. Lapane et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
Sulfonylurea Use and Risk of Hip Fractures Among Elderly Men and Women with Type 2 Diabetes
Swapnil N. Rajpathak et al.
DRUGS & AGING (2015)
The Impact of Diabetes and Diabetes Medications on Bone Health
Matthew P. Gilbert et al.
ENDOCRINE REVIEWS (2015)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETES CARE (2015)
Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials
Zhong-Ning Zhu et al.
BONE (2014)
The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses
W. G. Melsen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Clinical frailty and long-term mortality in elderly subjects with diabetes
Francesco Cacciatore et al.
ACTA DIABETOLOGICA (2013)
Sulfonylureas and Risk of Falls and Fractures: A Systematic Review
Kate L. Lapane et al.
DRUGS & AGING (2013)
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
H. M. Colhoun et al.
DIABETOLOGIA (2012)
A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes
Daniel H. Solomon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
Ioanna Tzoulaki et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic Patients A case-control study
Matteo Monami et al.
DIABETES CARE (2008)
Share Paper
